Effectively Screen Biotherapeutic Targets Using Carterra’s Powerful Software Suite
Read More
DDW Podcast: The Bamlanivimab story – how it reached the clinic in eight months
Read More
Dousing the Pandemic’s Flames
Read More
Picking the Best Antibody Therapeutic Candidates to Develop the Most Effective COVID-19 Therapeutic Cocktail
Read More
Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein
Read More
Nature Webinar: Accelerating Drug Discovery at a Pandemic Pace
Read More
Application Note: Monitoring Immune Response to SARS-CoV-2
Read More
The Coronavirus Immunotherapy Consortium (CoVIC) Uses HT-SPR To Identify the Most Potent, Mutation-Resistant Cocktails of Therapeutics Antibodies
Read More
Interview on the Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies
Watch Interview
Bamlanivimab (LY-CoV555) is the First COVID-19 Therapeutic Made Available to the Public by the FDA
Read More
